Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Carlsbad, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lineage Cell Therapeutics, Inc. has filed 1,802 SEC EDGAR filings since 17 Apr 1996

SEC filing history

Showing 201-225 of 1,000 matching filings.

Per page
25
Current page
9
4

4 filing

Filing date
15 Feb 2022
Reporting date
11 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Feb 2022
Reporting date
11 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Feb 2022
Reporting date
11 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Feb 2022
Reporting date
11 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
5

5 filing

Filing date
11 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-42290

SC 13G filing

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jan 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2021
Reporting date
28 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-254167

424B5 filing

Filing date
21 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12830

10-Q filing

Filing date
10 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
4

4 filing

Filing date
12 Oct 2021
Reporting date
30 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-259853

S-8 filing

Filing date
28 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Sep 2021
Reporting date
01 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-12830

DEFA14A filing

Filing date
02 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-12830

10-Q filing

Filing date
12 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .